General statements related to diabetes and COVID-19

« Terug naar het overzicht
diabetes en covid-19

General statements related to diabetes and COVID-19

Diabetes and coronavirus infection

There is no increased risk of infection with SARS-CoV-2 in people with diabetes.

COVID-19 and diabetes problems
With COVID-19 disease, people with diabetes are at risk of dysregulation of their blood sugar levels.

Extra attention to blood glucose control is required in case of fever or other COVID-19 symptoms, with adjustment of glucose-lowering medication (such as insulin). People with type 1 diabetes should be especially aware of diabetic ketoacidosis. If in doubt, contact the diabetes team.

Diabetes and COVID-19 course
Poor COVID-19 course (including increased risk of hospitalization, increased risk of hospitalization for intensive care, and increased risk of death) is more frequent in people with type 2 diabetes with multimorbidity: combined with overweight, arterial hypertension, cardiovascular disease, and kidney disease.

Poor COVID-19 course in these people is more frequent in people with poorly controlled diabetes.

There are no arguments for a worse COVID-19 course in people with type 1 diabetes than in the general population.

Note: Diabetes does not stop during the COVID-19 epidemic. Complications of diabetes (including foot problems, chest pain, and being unwell) should be monitored and if in doubt, contact the doctor or diabetes team.

Louvain
May 6, 2020